A dominant negative Cx43 mutant differentially affects tumorigenic and invasive properties in human metastatic melanoma cells

Journal of Cellular Physiology

Volumn 228, Issue 4, 2013, Pages 853-859

  Zucker, Shoshanna N ^a   Bancroft, Tara A ^a   Place, David E ^a   Des Soye, Benjamin ^a   Bagati, Archis ^a   Berezney, Ronald ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 26; CONNEXIN 30; CONNEXIN 31; CONNEXIN 32; CONNEXIN 36; CONNEXIN 37; CONNEXIN 40; CONNEXIN 43; CONNEXIN 45;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; METASTATIC MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CONNEXIN 43; HUMANS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, NUDE; NEOPLASM INVASIVENESS;

MUS MUSCULUS;

EID: 84871693724     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24235     Document Type: Article

References (46)

1. Beahm DL, Oshima A, Gaietta GM, Hand GM, Smock AE, Zucker SN, Toloue MM, Chandrasekhar A, Nicholson BJ, Sosinsky GE. 2006. Mutation of a conserved threonine in the third transmembrane helix of alpha- and beta-connexins creates a dominant-negative closed gap junction channel. J Biol Chem 281:7994-8009.
2. Cao Z, West C, Norton-Wenzel CS, Rej R, Davis FB, Davis PJ. 2009. Effects of resin or charcoal treatment on fetal bovine serum and bovine calf serum. Endocr Res 34:101-108.
3. Cesen-Cummings K, Fernstrom MJ, Malkinson AM, Ruch RJ. 1998. Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells. Carcinogenesis 19:61-67.
4. Dang X, Doble BW, Kardami E. 2003. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol Cell Biochem 242:35-38.
5. Di WL, Rugg EL, Leigh IM, Kelsell DP. 2001. Multiple epidermal connexins are expressed in different keratinocyte subpopulations including connexin 31. J Invest Dermatol 117:958-964.
6. Eghbali B, Kessler JA, Reid LM, Roy C, Spray DC. 1991. Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci USA 88:10701-10705.
7. Elzarrad MK, Haroon A, Willecke K, Dobrowolski R, Gillespie MN, Al-Mehdi AB. 2008. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med 6:20.
8. Friedman EA, Steinberg M. 1982. Disrupted communication between late-stage premalignant human colon epithelial cells by 12-O tetradecanoylphorbol-13-acetate. Cancer Res 42:5096-5109.
9. Giepmans BN, Moolenaar WH. 1998. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr Biol 8:931-934.
10. Giepmans BN, Verlaan I, Hengeveld T, Janssen H, Calafat J, Falk MM, Moolenaar WH. 2001. Gap junction protein connexin-43 interacts directly with microtubules. Curr Biol 11:1364-1368.
11. Goldberg GS, Bechberger JF, Naus CC. 1995. A pre-loading method of evaluating gap junctional communication by fluorescent dye transfer. Biotechniques 18:490-497.
12. Hanna EA, Umhauer S, Roshong SL, Piechocki MP, Fernstrom MJ, Fanning JD, Ruch RJ. 1997. Gap junctional intercellular communication and connexin43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro. Carcinogenesis 20:1369-1373.
13. Hirschi KK, Xu CE, Tsukamoto T, Sager R. 1996. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 7:861-870.
14. Huang GY, Cooper ES, Waldo K, Kirby ML, Gilula NB, Lo CW. 1998. Gap junction-mediated cell-cell communication modulates mouse neural crest migration. J Cell Biol 143:1725-1734.
15. Huang RP, Hossain MZ, Sehgal A, Boynton AL. 1999. Reduced connexin43 expression in high-grade human brain glioma cells. J Surg Oncol 70:21-24.
16. Jimenez T, Fox WP, Naus CC, Galipeau J, Belliveau DJ. 2006. Connexin over-expression differentially suppresses glioma growth and contributes to the bystander effect following HSV-thymidine kinase gene therapy. Cell Commun Adhes 13:79-92.
17. Jinn Y, Ichioka M, Marumo F. 1998. Expression of connexin32 and connexin43 gap junction proteins and E-cadherin in human lung cancer. Cancer Lett 127:161-169.
18. Kalra J, Shao Q, Qin H, Thomas T, Alaoui-Jamali MA, Laird DW. 2006. Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis 27:2528-2537.
19. Kanazawa Y, Ueda Y, Shimasaki M, Katsuda S, Yamamoto N, Tomita K, Tsuchiya H. 2008. Down-regulation of plakoglobin in soft tissue sarcoma is associated with a higher risk of pulmonary metastasis. Anticancer Res 28:655-664.
20. Kanczuga-Koda L, Sulkowski S, Lenczewski A, Koda M, Wincewicz A, Baltaziak M, Sulkowska M. 2006. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol 59:429-433.
21. Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon AM, Mesnil M, Berger F, Partensky C, Yamasaki H. 1994. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 56:87-94.
22. Laird DW. 2006. Life cycle of connexins in health and disease. Biochem J 394:527-543.
23. Lampe PD, Lau AF. 2004. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 36:1171-1186.
24. Lampe PD, Cooper CD, King TJ, Burt JM. 2006. Analysis of Connexin43 phosphorylated at S325, S328 and S330 in normoxic and ischemic heart. J Cell Sci 119:3435-3442.
25. Li G, Satyamoorthy K, Herlyn M. 2002. Dynamics of cell interactions and communications during melanoma development. Crit Rev Oral Biol Med 13:62-70.
26. Locke D. 1998. Gap junctions in normal and neoplastic mammary gland. J Pathol 186:343-349.
27. McLachlan E, Shao Q, Wang HL, Langlois S, Laird DW. 2006. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res 66:9886-9894.
28. Miekus K, Czernik M, Sroka J, Czyz J, Madeja Z. 2005. Contact stimulation of prostate cancer cell migration: The role of gap junctional coupling and migration stimulated by heterotypic cell-to-cell contacts in determination of the metastatic phenotype of Dunning rat prostate cancer cells. Biol Cell 97:893-903.
29. Moreno AP, Lau AF. 2007. Gap junction channel gating modulated through protein phosphorylation. Prog Biophys Mol Biol 94:107-119.
30. Naus CC. 2002. Gap junctions and tumour progression. Can J Physiol Pharmacol 80:136-141.
31. Nicholson BJ. 2003. Gap junctions-From cell to molecule. J Cell Sci 116:4479-4481.
32. Qin H, Shao Q, Curtis H, Galipeau J, Belliveau DJ, Wang T, Alaoui-Jamali MA, Laird DW. 2002. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem 277:29132-29138.
33. Rea JC, Barron AE, Shea LD. 2008. Peptide-mediated lipofection is governed by lipoplex physical properties and the density of surface-displayed amines. J Pharm Sci 97:4794-4806.
34. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. 2003. Plasma membrane channels formed by connexins: Their regulation and functions. Physiol Rev 83:1359-1400.
35. Sohl G, Willecke K. 2004. Gap junctions and the connexin protein family. Cardiovasc Res 62:228-232.
36. Solan JL, Lampe PD. 2009. Connexin43 phosphorylation: Structural changes and biological effects. Biochem J 419:261-272.
37. Solan JL, Marquez-Rosado L, Sorgen PL, Thornton PJ, Gafken PR, Lampe PD. 2007. Phosphorylation at S365 is a gatekeeper event that changes the structure of Cx43 and prevents down-regulation by PKC. J Cell Biol 179:1301-1309.
38. Sosinsky GE, Solan JL, Gaietta GM, Ngan L, Lee GJ, Mackey MR, Lampe PD. 2007. The C-terminus of connexin43 adopts different conformations in the golgi and gap junction as detected with structure-specific antibodies. Biochem J 408:375-385.
39. Su YA, Bittner ML, Chen Y, Tao L, Jiang Y, Zhang Y, Stephan DA, Trent JM. 2000. Identification of tumor-suppressor genes using human melanoma cell lines UACC903, UACC903(+6), and SRS3 by comparison of expression profiles. Mol Carcinog 28:119-127.
40. Tada J, Hashimoto K. 1997. Ultrastructural localization of gap junction protein connexin 43 in normal human skin, basal cell carcinoma, and squamous cell carcinoma. J Cutan Pathol 24:628-635.
41. Tsai H, Werber J, Davia MO, Edelman M, Tanaka KE, Melman A, Christ GJ, Geliebter J. 1996. Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochem Biophys Res Commun 227:64-69.
42. Uchida Y, Matsuda K, Sasahara K, Kawabata H, Nishioka M. 1995. Immunohistochemistry of gap junctions in normal and diseased gastric mucosa of humans. Gastroenterology 109:1492-1496.
43. Wolkowicz R, Nolan GP. 2003. Retroviral technology-Applications for expressed peptide libraries. Front Biosci 8:d603-d619.
44. Xu X, Li WE, Huang GY, Meyer R, Chen T, Luo Y, Thomas MP, Radice GL, Lo CW. 2001. Modulation of mouse neural crest cell motility by N-cadherin and connexin 43 gap junctions. J Cell Biol 154:217-230.
45. Yamasaki H, Omori Y, Krutovskikh V, Zhu W, Mironov N, Yamakage K, Mesnil M. 1999. Connexins in tumour suppression and cancer therapy. Novartis Found Symp 219:241-254, discussion 254-60.
46. Yeager M. 1998. Structure of cardiac gap junction intercellular channels. J Struct Biol 121:231-245.